Earendil Labs and WuXi Biologics Partner on Bispecific Antibodies and ADCs
Under the agreement, WuXi Biologics will provide end-to-end development and manufacturing services to Earendil Labs, supporting faster regulatory timelines, reliable CMC execution, and scalable global clinical development.
ADCs | 13/03/2026 | By News Bureau
Axplora Expands Commercial ADC Manufacturing with New Workshop Launch in France
This expansion, which is part of the France 2030 program, builds on Axplora’s proven commercial track record, supplying 40 percent of the world’s marketed ADCs, and 50 percent of FDA-approved ADCs.
ADCs | 05/03/2025 | By Aishwarya | 560
NJ Bio Partners with Charles River to Accelerate ADC Development
The biggest benefit of the Charles River and NJ Bio alliance is that clients can receive seamless complementary services to enhance outcomes and accelerate time-to-market for their ADCs.
ADCs | 08/11/2024 | By Aishwarya | 270
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy